Compare ENTA & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | TLS |
|---|---|---|
| Founded | 1995 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.6M | 317.1M |
| IPO Year | 2012 | 2020 |
| Metric | ENTA | TLS |
|---|---|---|
| Price | $12.50 | $4.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $20.40 | $7.90 |
| AVG Volume (30 Days) | 143.3K | ★ 967.8K |
| Earning Date | 05-11-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.93 | ★ 31.51 |
| EPS | ★ N/A | N/A |
| Revenue | $102,814,000.00 | ★ $164,805,000.00 |
| Revenue This Year | $7.76 | $18.72 |
| Revenue Next Year | N/A | $14.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 16.48 | ★ 52.21 |
| 52 Week Low | $4.09 | $1.83 |
| 52 Week High | $17.15 | $8.36 |
| Indicator | ENTA | TLS |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 45.69 |
| Support Level | $12.09 | $3.80 |
| Resistance Level | $15.52 | $4.73 |
| Average True Range (ATR) | 0.78 | 0.34 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 36.00 | 25.31 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.